VeriMomDois-je éviter valproic acid pendant la grossesse ? | VeriMom
Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
ECHA regulatory hazard statements
- •H360
- •H362
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- valproic acid est-il sûr pendant la grossesse ?
- Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
- valproic acid est-il sûr pendant l'allaitement ?
- Valproic acid is listed with H362 (may cause harm to breast‑fed children) in ECHA/SDS documents and transfers into breast milk in clinical/toxicology literature; the mechanistic actions that produce developmental neurotoxicity are the same basis for concern. For a cosmetic topical route maternal systemic levels would usually be low, so exposure via breastmilk from cosmetic use is expected to be low but measurable (e=1).
- valproic acid est-il sûr pour la peau de bébé ?
- Hazard remains high because VPA is a confirmed human developmental/teratogenic agent and H360/H362 are reported; mechanism (HDAC inhibition, disruption of developmental signalling) is well characterised. If VPA were present on infant skin (0–3 yrs) dermal absorption is more significant than in adults; per your rules increase exposure by +1 when measurable — cosmetic topical adult e=1 becomes baby e=2. There are no infant‑topical specific safety data showing safe use on baby skin.
- Comment VeriMom évalue-t-il valproic acid ?
- VeriMom évalue valproic acid à 13/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à valproic acid pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à valproic acid basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.